Found: 54
Select item for more details and to access through your institution.
Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal".
- Published in:
- 2017
- By:
- Publication type:
- Letter
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Headroom Analysis for Early Economic Evaluation: A Systematic Review.
- Published in:
- Applied Health Economics & Health Policy, 2023, v. 21, n. 2, p. 195, doi. 10.1007/s40258-022-00774-5
- By:
- Publication type:
- Article
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties.
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 4, p. 429, doi. 10.1007/s40258-018-0393-7
- By:
- Publication type:
- Article
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29286-5
- By:
- Publication type:
- Article
Telemonitoring in patients with heart failure: Is there a long-term effect?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adherence Among Telemonitored Patients with Heart Failure to Pharmacological and Nonpharmacological Recommendations.
- Published in:
- Telemedicine & e-Health, 2009, v. 15, n. 6, p. 517, doi. 10.1089/tmj.2009.0160
- By:
- Publication type:
- Article
Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S026646232300260X
- By:
- Publication type:
- Article
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an In Silico Clinical Trial and a Cost–Utility Study.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2687, doi. 10.3390/cancers13112687
- By:
- Publication type:
- Article
Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 722, doi. 10.3390/cancers13040722
- By:
- Publication type:
- Article
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 485, doi. 10.1007/s10549-017-4374-6
- By:
- Publication type:
- Article
Clinically inappropriate post hoc exclusion of study participants from test accuracy calculations: the ROMA score, an example from a recent NICE diagnostic assessment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230909
- By:
- Publication type:
- Article
Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
- Published in:
- 2021
- By:
- Publication type:
- Letter
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation.
- Published in:
- Health Technology Assessment, 2021, v. 25, n. 33, p. v, doi. 10.3310/hta25330
- By:
- Publication type:
- Article
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 1, p. 237, doi. 10.1093/clinchem/hvaa280
- By:
- Publication type:
- Article
Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study.
- Published in:
- European Journal of Preventive Cardiology, 2020, v. 27, n. 13, p. 1354, doi. 10.1177/2047487320913380
- By:
- Publication type:
- Article
Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 3, p. 205, doi. 10.1007/s40273-014-0231-1
- By:
- Publication type:
- Article
Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Acknowledging Patient Heterogeneity in Economic Evaluation.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 111, doi. 10.1007/s40273-012-0015-4
- By:
- Publication type:
- Article
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
- Published in:
- 2021
- By:
- Publication type:
- Letter
The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00241
- By:
- Publication type:
- Article
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 829, doi. 10.1007/s40273-024-01394-8
- By:
- Publication type:
- Article
A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 797, doi. 10.1007/s40273-024-01376-w
- By:
- Publication type:
- Article
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 4, p. 419, doi. 10.1007/s40273-023-01344-w
- By:
- Publication type:
- Article
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 6, p. 619, doi. 10.1007/s40273-023-01242-1
- By:
- Publication type:
- Article
Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 1, p. 33, doi. 10.1007/s40273-022-01209-8
- By:
- Publication type:
- Article
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 12, p. 1429, doi. 10.1007/s40273-021-01073-y
- By:
- Publication type:
- Article
State of the ART? Two New Tools for Risk Communication in Health Technology Assessments.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 10, p. 1185, doi. 10.1007/s40273-021-01060-3
- By:
- Publication type:
- Article
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2020
- By:
- Publication type:
- journal article
R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function.
- Published in:
- International Journal of Cardiovascular Imaging, 2023, v. 39, n. 5, p. 915, doi. 10.1007/s10554-023-02796-z
- By:
- Publication type:
- Article
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.
- Published in:
- Health Technology Assessment, 2024, v. 28, n. 11-15, p. v, doi. 10.3310/RDPA1487
- By:
- Publication type:
- Article
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Letter
An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 9, p. 1123, doi. 10.1080/0284186X.2020.1775289
- By:
- Publication type:
- Article